NTD Network goes online: our seminar programme for 2020!
With COVID-19 curtailing everyone’s movements worldwide, our Network members are now meeting online! Our seminar series launched last week, and will run through the rest of this year, with talks scheduled from our Network HUB leads and Network Fellows. Please note these seminars are closed meetings, for our current NTD Network members and their teams, plus our international advisory panel – if this includes you, there will be email updates ahead of each meeting, with instructions on how to join the meetings. Click ‘more’ for the timetable and speakers schedule. We hope to see you soon!
Section 1: HUB Leads |
||
Date |
Speaker |
Title |
Wednesday3rd June |
Prof Ariel SiberUniversity of Sao Paulo, Brazil |
How Trypanosoma cruzi uses metabolism to cope with its highly dangerous lifestyle |
Host: Dr Brian Mantilla, Durham University |
||
Wednesday17th June, 2020 |
Professor Nahid AliCouncil of Scientific & Industrial Research – Indian Institute of Chemical Biology (CSIR-IICB) Kolkata, India |
New antigenic markers for diagnosis of visceral leishmaniasis |
Host: Dr Kalesh Karunakaran, Durham University |
||
Wednesday1st July, 2020 |
Prof Iqbal ChoudharyInternational Center for Chemical and Biological Sciences (ICCBS), University of Karachi) |
Generating Chemical Space for Anti-leishmanial Drug Discovery and Development – Phenotypic Screening, Pre-Clinical and Clinical Studies |
Host: Dr Hachemi Kadri, Durham University |
||
Wednesday15th July, 2020 |
Professor Paul DennyCentre for Global Infectious Diseases, Durham University |
Protozoan ‘drug’ discovery: old drugs, new targets and mining for novelty |
Host: Dr Katrien van Bocxlaer, University of York |
Section 2: Network Fellows |
||
Date |
Speaker |
Title |
Wednesday16th September 2020Host: Dr Paul Denny (Durham, UK |
Dr Kalesh Karunakaran (Durham University) |
“Chemical proteomics for unravelling stress adaptation mechanisms in Leishmania”. |
Dr Nathanial Jones (University of York) |
“Validation and characterisation of Leishmania bromodomain factors as potential drug targets” |
|
Dr Hachemi Kadri (Durham University) |
“Innovative drug discovery strategies for Neglected Tropical Diseases” |
|
Wednesday7th October, 2020Host: Dr Paul Denny (Durham, UK) |
Dr Brian MantillaCentre for Global Infectious Diseases, Durham University |
Understanding Inositol Pyrophosphate IP7 functions in Leishmania parasites |
Dr Katrien van BocxlaerUniversity of York, UK |
Drug development for CL: a snapshot |